Publications by Researcher: Miles, LA

Year	Title	Author(s)
2012	Structural approaches to probing metal interaction with proteins Journal Of Inorganic Biochemistry	Parker, LJ Ascher, DB Gao, C Miles, LA Harris, HH Parker, MW
2013	Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation Scientific Reports	Miles, LA Crespi, GAN Doughty, L Parker, MW
2013	Synthetic dityrosine-linked beta-amyloid dimers form stable, soluble, neurotoxic oligomers Chemical Science	Kok, WM Cottam, JM Ciccotosto, GD Miles, LA Karas, JA Scanlon, DB Roberts, BR Parker, MW Cappai, R Barnham, KJ Hutton, CA
2014	Crystallization and preliminary X-ray diffraction analysis of the Fab portion of the Alzheimer's disease immunotherapy candidate bapineuzumab complexed with amyloid-beta Acta Crystallographica Section F-structural Biology And Crystallization Communications	Crespi, GAN Ascher, DB Parker, MW Miles, LA
2014	Anti-A beta antibody target engagement: a response to Siemers et al. Acta Neuropathologica	Watt, AD Crespi, GAN Down, RA Ascher, DB Gunn, A Perez, KA McLean, CA Villemagne, VL Parker, MW Barnham, KJ Miles, LA
2014	Do current therapeutic anti-A beta antibodies for Alzheimer's disease engage the target? Acta Neuropathologica	Watt, AD Crespi, GAN Down, RA Ascher, DB Gunn, A Perez, KA McLean, CA Villemagne, VL Parker, MW Barnham, KJ Miles, LA
2015	Molecular basis for mid-region amyloid-beta capture by leading Alzheimer's disease immunotherapies Scientific Reports	Crespi, GAN Hermans, SJ Parker, MW Miles, LA
2015	Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-trunc Acta Neuropathologica	Bouter Y Noguerola JSL Tucholla P Crespi GAN Parker, MW Wiltfang J Miles, LA Bayer TA
2015	Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models Acta Neuropathol.	Bouter, Y Noguerola, JSL Tucholla, P Crespi, GAN Parker, MW Wiltfang, J Miles, LA Bayer, TA
2017	Ex vivo O-18-labeling mass spectrometry identifies a peripheral amyloid beta clearance pathway Mol. Neurodegener.	Portelius, E Mattsson, N Pannee, J Zetterberg, H Gisslen, M Vanderstichele, H Gkanatsiou, E Crespi, GAN Parker, MW Miles, LA Gobom, J Blennow, K
2017	Promiscuous DNA-binding of a mutant zinc finger protein corrupts the transcriptome and diminishes cell viability Nucleic Acids Res.	Gillinder, KR Ilsley, MD Nebor, D Sachidanandam, R Lajoie, M Magor, GW Tallack, MR Bailey, T Landsberg, MJ Mackay, JP Parker, MW Miles, LA Graber, JH Peters, LL Bieker, JJ Perkins, AC
2017	Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites Nat. Commun.	Braig, D Nero, TL Koch, HG Kaiser, B Wang, XW Thiele, JR Morton, CJ Zeller, J Kiefer, J Potempa, LA Mellett, NA Miles, LA Du, XJ Meikle, PJ Huber-Lang, M Stark, GB Parker, MW Peter, K Eisenhardt, SU
2019	Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes A beta Phagocytosis Iscience	Miles, LA Hermans, SJ Crespi, GAN Gooi, JH Doughty, L Nero, TL Markulic, J Ebneth, A Wroblowski, B Oehlrich, D Trabanco, AA Rives, ML Royaux, I Hancock, NC Parker, MW
2020	N-terminal heterogeneity of parenchymal and vascular amyloid-beta deposits in Alzheimer's disease Neuropathology And Applied Neurobiology	Zampar, S Klafki, HW Sritharen, K Bayer, TA Wiltfang, J Rostagno, A Ghiso, J Miles, LA Wirths, O